XP Inc. logo XP - XP Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 7
HOLD 2
SELL 0
STRONG
SELL
0
| PRICE TARGET: $24.57 DETAILS
HIGH: $33.00
LOW: $19.00
MEDIAN: $24.00
CONSENSUS: $24.57
UPSIDE: 47.21%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Banks, Insurers & Asset Managers 90% confidence

Primary model: P/Tangible Book × ROE Quality

Valuation Signal Undervalued Strong
Trading 51.3% below fair value
Current Price $16.69
Bear Case $23.98 43.7% upside ($23.98 - $16.69) / $16.69 = 43.7% ROTCE 18.3% → 2.21x TBV
Fair Value $34.26 105.3% upside ($34.26 - $16.69) / $16.69 = 105.3% ROTCE 24.4% → 3.15x TBV
Bull Case $44.54 166.9% upside ($44.54 - $16.69) / $16.69 = 166.9% ROTCE 28.0% → 3.72x TBV

Adjust Assumptions

24.4%
10.5%

Key Value Driver

ROTCE (24.4%) vs. cost of equity (10.5%)

Implied Market Multiple 2.13x

Plain-Language Summary

Our base-case estimate uses P/Tangible Book × ROE Quality. We then blend that result with the average analyst price target of $24.57 from 9 analysts, using a 20% weight on analyst consensus. That produces an estimated intrinsic value of $34.26 per share.

Warnings

Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.
Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.
Wall Street's average price target is $24.57 (from 9 analysts). Our estimate is 49% above the consensus -- consider that gap carefully.
Financial statements were converted from BRL into USD using USDBRL at 0.1970 USD per BRL.

Key Risks

  • Book value quality matters as much as level — check loan loss reserves
  • Interest rate sensitivity creates non-linear earnings surprises
  • Insurance reserving is actuarial, not financial — errors emerge slowly